Published online before print May 2, 2005, doi: 10.1161/01.CIR.0000164270.72123.18
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2005;111:2313-2318.)
© 2005 American Heart Association, Inc.
Heart Failure |
Peak Oxygen Consumption as a Predictor of Death in Patients With Heart Failure Receiving ß-Blockers
From the Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio.
Reprint requests to Michael S. Lauer, MD, FACC, Dept of Cardiovascular Medicine, The Cleveland Clinic Foundation, Desk F25, 9500 Euclid Ave, Cleveland, OH 44195. E-mail Lauerm{at}ccf.org
Received November 26, 2004; revision received January 12, 2005; accepted January 20, 2005.
Background— Peak oxygen uptake (peak 
O2) is a strong predictor of mortality and is commonly used in the evaluation of patients for cardiac transplantation. ß-Blockers reduce mortality in patients with heart failure, without influencing peak O2, raising the possibility that peak O2 is no longer suitable as an indicator of prognosis in these patients.
Methods and Results— We analyzed prospectively gathered data on 2105 patients referred for cardiopulmonary testing for all-cause mortality and for occurrence of death or transplantation. Patients receiving ß-blockers were younger, more likely to have coronary disease, and had a greater mean ejection fraction but had a similar peak O2. There were 555 deaths (26%) and 194 (9%) transplants during a median follow-up of 3.5 years. Peak O2 was a predictor of mortality irrespective of ß-blocker use; a decrease of 1 mL · kg–1 · min–1 resulted in an adjusted hazard ratio (HR) of 1.13 (95% CI 1.09 to 1.17, P<0.0001) in patients not receiving ß-blockers and 1.27 (95% CI 1.18 to 1.36, P<0.0001) in patients receiving ß-blockers. Similar findings were noted when considering death or transplantation as an end point. ß-Blocker use was associated with better outcomes until peak O2 values became very low (
10 mL · kg–1 · min–1), at which level survival rates were equally poor.
Conclusion— Peak O2 is a determinant of survival in patients in heart failure even in the setting of ß-blockade. Because of improved survival in patients treated with ß-blockers, the cut point value of 14 mg · kg–1 · min–1 for referral for cardiac transplantation in these patients requires reevaluation, and a lower cut point may be more appropriate.
Key Words: heart failure • exercise • adrenergic beta-antagonists • prognosis • ventricular dysfunction, left
This article has been cited by other articles:
 |
|
 |
|
  E. Hsich, E. Z. Gorodeski, R. C. Starling, E. H. Blackstone, H. Ishwaran, and M. S. Lauer Importance of Treadmill Exercise Time as an Initial Prognostic Screening Tool in Patients With Systolic Left Ventricular Dysfunction Circulation, June 30, 2009; 119(25): 3189 - 3197. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Corra, A. Mezzani, A. Giordano, E. Bosimini, and P. Giannuzzi Exercise haemodynamic variables rather than ventilatory efficiency indexes contribute to risk assessment in chronic heart failure patients treated with carvedilol Eur. Heart J., April 30, 2009; (2009) ehp138v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. P. Kalogeropoulos, V. V. Georgiopoulou, G. Giamouzis, A. L. Smith, S. A. Agha, S. Waheed, S. Laskar, J. Puskas, S. Dunbar, D. Vega, et al. Utility of the Seattle heart failure model in patients with advanced heart failure. J. Am. Coll. Cardiol., January 27, 2009; 53(4): 334 - 342. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. C. Lang, P. Karlin, J. Haythe, T. K. Lim, and D. M. Mancini Peak Cardiac Power Output, Measured Noninvasively, Is a Powerful Predictor of Outcome in Chronic Heart Failure Circ Heart Fail, January 1, 2009; 2(1): 33 - 38. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Arena, J. Myers, and M. Guazzi The Clinical Significance of Aerobic Exercise Testing and Prescription: From Apparently Healthy to Confirmed Cardiovascular Disease American Journal of Lifestyle Medicine, November 1, 2008; 2(6): 519 - 536. [Abstract] [PDF]
|
|
|
|
 |
|
 G. V. Guimaraes, V. M. d'Avila, P. R. Camargo, L. F. P. Moreira, J. R. L. Luces, and E. A. Bocchi Prognostic value of cardiopulmonary exercise testing in children with heart failure secondary to idiopathic dilated cardiomyopathy in a non-{beta}-blocker therapy setting Eur J Heart Fail, June 1, 2008; 10(6): 560 - 565. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Pantos, A. Dritsas, I. Mourouzis, A. Dimopoulos, G. Karatasakis, G. Athanassopoulos, S. Mavrogeni, A. Manginas, and D. V Cokkinos Thyroid hormone is a critical determinant of myocardial performance in patients with heart failure: potential therapeutic implications Eur. J. Endocrinol., October 1, 2007; 157(4): 515 - 520. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Jankowska, T. Witkowski, B. Ponikowska, K. Reczuch, L. Borodulin-Nadzieja, S. D. Anker, M. F. Piepoli, W. Banasiak, and P. Ponikowski Excessive ventilation during early phase of exercise: A new predictor of poor long-term outcome in patients with chronic heart failure Eur J Heart Fail, October 1, 2007; 9(10): 1024 - 1031. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Guazzi, R. Raimondo, M. Vicenzi, R. Arena, C. Proserpio, S. Sarzi Braga, and R. Pedretti Exercise oscillatory ventilation may predict sudden cardiac death in heart failure patients. J. Am. Coll. Cardiol., July 24, 2007; 50(4): 299 - 308. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Arena, J. Myers, M. A. Williams, M. Gulati, P. Kligfield, G. J. Balady, E. Collins, and G. Fletcher Assessment of Functional Capacity in Clinical and Research Settings: A Scientific Statement From the American Heart Association Committee on Exercise, Rehabilitation, and Prevention of the Council on Clinical Cardiology and the Council on Cardiovascular Nursing Circulation, July 17, 2007; 116(3): 329 - 343. [Full Text] [PDF]
|
|
|
|
|
|
M. Metra, P. Ponikowski, K. Dickstein, J. J.V. McMurray, A. Gavazzi, C.-H. Bergh, A. G. Fraser, T. Jaarsma, A. Pitsis, P. Mohacsi, et al. Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology Eur J Heart Fail, June 1, 2007; 9(6-7): 684 - 694. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Mancini and T. H. LeJemtel Is Ventilatory Classification Preferable to Peak Oxygen Consumption for Risk Stratification in Heart Failure? Circulation, May 8, 2007; 115(18): 2376 - 2378. [Full Text] [PDF]
|
|
|
|
|
|
O. Oldenburg, B. Lamp, L. Faber, H. Teschler, D. Horstkotte, and V. Topfer Sleep-disordered breathing in patients with symptomatic heart failure A contemporary study of prevalence in and characteristics of 700 patients Eur J Heart Fail, March 1, 2007; 9(3): 251 - 257. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. H. Zou, A. J. O'Malley, and L. Mauri Receiver-Operating Characteristic Analysis for Evaluating Diagnostic Tests and Predictive Models Circulation, February 6, 2007; 115(5): 654 - 657. [Full Text] [PDF]
|
|
|
|
|
|
C. E. Canter, R. E. Shaddy, D. Bernstein, D. T. Hsu, M. R.K. Chrisant, J. K. Kirklin, K. R. Kanter, R. S.D. Higgins, E. D. Blume, D. N. Rosenthal, et al. Indications for Heart Transplantation in Pediatric Heart Disease: A Scientific Statement From the American Heart Association Council on Cardiovascular Disease in the Young; the Councils on Clinical Cardiology, Cardiovascular Nursing, and Cardiovascular Surgery and Anesthesia; and the Quality of Care and Outcomes Research Interdisciplinary Working Group Circulation, February 6, 2007; 115(5): 658 - 676. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Passantino, R. Lagioia, F. Mastropasqua, and D. Scrutinio Short-Term Change in Distance Walked in 6 Min Is an Indicator of Outcome in Patients With Chronic Heart Failure in Clinical Practice J. Am. Coll. Cardiol., July 4, 2006; 48(1): 99 - 105. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Gardner, T. A. McDonagh, M. MacDonald, H. J. Dargie, A. J. Murday, and M. C. Petrie Who needs a heart transplant? Eur. Heart J., April 1, 2006; 27(7): 770 - 772. [Full Text] [PDF]
|
|
|
|
|
|
R. L. Bard, M. S. Lauer, J. O. O'Neill, C. E. Pothier, and J. B. Young Letter Regarding Article by O'Neill et al, "Peak Oxygen Consumption as a Predictor of Death in Patients With Heart Failure Receiving {beta}-Blockers" * Response Circulation, October 18, 2005; 112(16): e271 - e271. [Full Text] [PDF]
|
|